Man Group
LEGN icon

Man Group’s Legend Biotech LEGN Stock Holding History

Man Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$445K Sell
24,604
-37,100
-60% -$707K ﹤0.01% 2121
2025
Q4 		$1.34M Buy
61,704
+27,900
+83% +$799K ﹤0.01% 1595
2025
Q3 		$1.1M Buy
33,804
+18,604
+122% +$687K ﹤0.01% 1634
2025
Q2 		$539K Buy
+15,200
New +$493K ﹤0.01% 1807
2023
Q1 		– Sell
-17,449
Closed -$871K – 2173
2022
Q4 		$871K Sell
17,449
-5,478
-24% -$265K ﹤0.01% 1353
2022
Q3 		$935K Buy
+22,927
New +$1.08M ﹤0.01% 1309
2022
Q2 		– Sell
-9,627
Closed -$407K – 1546
2022
Q1 		$350K Buy
+9,627
New +$380K ﹤0.01% 1699

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Man Group's LEGN Position: Q1 2026 in Review

Man Group reduced its Legend Biotech (LEGN) stake by 60% in Q1 2026, selling an estimated $707K and leaving 24,604 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Man Group first reported a position in LEGN in Q1 2022 and has held it in 7 quarters since. The position peaked at $1.34M in Q4 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Man Group held 24,604 shares of Legend Biotech worth $445K as of Q1 2026.
  • Man Group sold 37,100 Legend Biotech shares in Q1 2026, an estimated $707K.
  • Legend Biotech made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2121 holding.
  • Man Group first reported a position in Legend Biotech in Q1 2022 and has held it in 7 quarters since.
  • Man Group's Legend Biotech position peaked at $1.34M in Q4 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.